• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these medications could affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication for odd and adhd during pregnancy do not develop neurological disorders such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are pregnant and taking Adhd medication Pregnancy medications must weigh the benefits of using them against the risks to the foetus. Physicians don't have the information needed to make unequivocal recommendations, but they can provide information about risks and benefits that assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not have an higher risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a massive population-based case control study to assess the frequency of structural defects that were major in infants born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists looked over the cases to ensure an accurate classification of the cases and to reduce the chance of bias.

The research conducted by the researchers had some limitations. The researchers were not able, in the first place to distinguish the effects of the medication from the disorder. This makes it difficult to know whether the small differences observed in the exposed groups result from medication use or the confounding effect of comorbidities. Additionally, the researchers did not examine the long-term outcomes of offspring.

The study did find that infants whose mothers had taken prescribe adhd medication medication during pregnancy were at slightly greater risk of being admitted to the neonatal intensive care unit (NICU) than infants who whose mothers did not take any medication or had stopped their medications before or during pregnancy. This increase was due to central nervous system disorders, and the higher risk of admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher chance of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

Researchers suggest that the minor risk of using ADHD medications in early pregnancies can be offset by greater benefits for mother and baby from continuing treatment for the woman's disorder. Physicians should speak with their patients about this and as much as possible, assist them develop coping skills that can lessen the impact of her disorder in her daily life and relationships.

Interactions with Medication

More and more doctors are faced with the decision of whether to continue treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made without solid and reliable evidence regardless, so doctors must weigh what they know, the experiences of other doctors, and what the research suggests on the subject, along with their best judgment for each patient.

The issue of potential risks for infants can be difficult to determine. A lot of studies on this topic are based on observations rather than controlled research and their findings are often contradictory. In addition, most studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study presented in the journal club addresses these limitations by analyzing data on live and deceased births.

Conclusion: While some studies have found a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. Most studies show a neutral, or even slightly negative, effect. In all cases, a careful study of the benefits and risks is required.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In an article published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of loneliness and family conflict for patients with ADHD. The loss of medication can affect the ability to safely drive and perform work-related tasks, which are essential aspects of everyday life for people with ADHD.

She recommends women who are unsure about whether to continue or stop medication in light types of adhd medication their pregnancy consider informing family members, friends and colleagues on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. It can also help women feel more confident in her decision. It is important to note that certain drugs can pass through the placenta so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be passed on to the baby.

Birth Defects and Risk of

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns over the impact that these drugs could have on foetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Utilizing two huge data sets, researchers were able to examine more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. Researchers found that while the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The authors of the study found no association between early use of medication and other congenital anomalies, such as facial clefting or club foot. The results are consistent with previous studies that have shown an increase, but not significant, in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter stages of pregnancy when a large number of women decided to stop taking their medication.

Women who were taking ADHD medication in the first trimester were more likely require a caesarean birth, have an insufficient Apgar after birth and had a baby that required breathing assistance at birth. However, the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have any other medical conditions that could have contributed to these findings.

The researchers hope that their research will aid in the clinical decisions of doctors who see pregnant women. They advise that while the discussion of the risks and benefits is crucial but the decision to stop or maintain medication must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it is not an option that is recommended due to the high prevalence of depression and other mental health issues among women who are pregnant or who are recently post-partum. Furthermore, research suggests that women who decide to stop taking their medication are more likely to have a difficult time adjusting to life without them after the baby's arrival.

Nursing

The responsibilities of a new mother can be overwhelming. Women who suffer from ADHD who have to manage their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. As such, many women decide to continue taking their ADHD medication throughout the pregnancy.

The risk to nursing infant is low because the majority of stimulant medication passes through breast milk at a low level. The rate of exposure to medication can vary depending upon the dosage and frequency of administration as well as the time of the day. In addition, different medications are introduced into the baby's system via the gastrointestinal tract, or through breast milk. The impact of these medications on a newborn's health is not completely understood.

Because of the lack of evidence, some doctors may be inclined to discontinue stimulant medications during the course of pregnancy. This is a complicated decision for the patient, who must balance the benefits of keeping her medication against the possible dangers to the embryo. Until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their ADHD medication safely during pregnancy and breast-feeding. In response, a growing number of patients are opting to continue their medication. They have discovered, in consultation with their doctors that the benefits of continuing their current medication outweigh any risk.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber, and the pros and cons of continuing treatment. This includes non-pharmacological strategies. Psychoeducation is also required to help pregnant women with ADHD be aware of the symptoms and underlying disorder. They should also be informed about treatment options and strengthen strategies for coping. This should be a multidisciplinary approach, which includes the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and child, and monitoring for signs of deterioration and, if necessary adjustments to the medication regime.